Novel asymmetric 3,5-bis(arylidene)piperidin-4-one derivatives : synthesis, crystal structures and cytotoxicity

3,5-Bis(arylidene)piperidin-4-one derivatives (BAPs) display good antitumour activity because of their double α,β-unsaturated ketone structural characteristics. Reported BAPs have generally been symmetric and asymmetric BAPs have been little documented. Three asymmetric BAPs, namely (5E)-3-(4-tert-butylbenzylidene)-5-(4-fluorobenzylidene)-1-methylpiperidin-4-one, C24H26FNO, (5), (5E)-3-(4-tert-butylbenzylidene)-5-(3,5-dimethoxybenzylidene)-1-methylpiperidin-4-one, C26H31NO3, (6), and (5E)-3-{3-[(E)-(2,3-dihydroxybenzylidene)amino]benzylidene}-5-(2-fluorobenzylidene)-1-methylpiperidin-4-one, C27H23FN2O3, (12), were generated by Claisen-Schmidt condensation. They are characterized by NMR and FT-IR spectroscopies, and elemental analysis. Single-crystal structure analysis reveals that the two arylidene rings on both sides of the BAP structures adopt an E stereochemistry of the olefinic double bonds and the compounds are E,E isomers. Molecules of (5) and (12) generate one-dimensional chains through intermolecular hydrogen bonds, while compound (6) generates a two-dimensional network through hydrogen bonds. Preliminary cytotoxicities toward human liver hepatocellular carcinoma cell line (HepG2), human acute mononuclear granulocyte leukaemia (THP-1) and human normal hepatical cell line (LO2) were evaluated.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:74

Enthalten in:

Acta crystallographica. Section C, Structural chemistry - 74(2018), Pt 6 vom: 01. Juni, Seite 659-665

Sprache:

Englisch

Beteiligte Personen:

Yao, Binrong [VerfasserIn]
Li, Ning [VerfasserIn]
Wang, Chunhua [VerfasserIn]
Hou, Guige [VerfasserIn]
Meng, Qingguo [VerfasserIn]
Yan, Ke [VerfasserIn]

Links:

Volltext

Themen:

Antineoplastic Agents
Asymmetric
Claisen-Schmidt condensation
Crystal structure
Cytotoxicity
DAP
Journal Article
Piperidin-4-one
Piperidines
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 13.11.2018

Date Revised 13.11.2018

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1107/S2053229618006605

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM285149873